Both in Biotechnology
Compass Therapeutics vs Humacyte
Over the past year CMPX returned −79.9% and HUMA returned −72.3%; their daily moves had a correlation of -0.01.
CMPX −79.9% HUMA −72.3%Growth of $1, one year, split-adjusted
| Metric | CMPX | HUMA |
|---|---|---|
| Price | $0.7530 | $0.4405 |
| Market cap | $135.6M | $122.4M |
| Today | −1.89% | +10.65% |
| 1 month | −21.6% | −11.9% |
| 6 months | −61.4% | −51.2% |
| Year to date | −86.0% | −54.1% |
| 1 year | −79.9% | −73.6% |
| Revenue growth (YoY) | — | +34.9% |
| Gross margin | — | −203.2% |
| Net margin | — | −9064.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 57.7× |
| Net cash | $179.9M | $13.7M |
| Dividend yield | — | — |
| Volatility (60d) | 100.4% | 108.0% |
| Short % of float | 33.9% | 11.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).